Clinical trial update from the Myelin Repair Foundation:
“The MRF and the NIH see a tremendous opportunity to investigate the repurposing of this drug to protect and repair myelin in multiple sclerosis patients.”

Scott Johnson
MRF President, Founder and CEO
http://www.myelinrepair.org/mrf-008.shtml

The Myelin Repair Foundation is an innovative research foundation focusing on developing drug therapies for multiple sclerosis patients.